Novo had asked the court to halt Lilly advertising it objected to. The judge ruled against the request on October 26, Reuters reports.
Recap by typeshit. Full story at Reuters on MSN.
Even genuine pens with foreign prescriptions are seized. Lawmakers and a regulatory official now want a review, as Mounjaro costs over three times more in Korea than Japan.
Law360 reports the European patent court could limit the use of divisional patents in a fight involving Novo Nordisk and Ozempic.
The think tank argues regulated compounding beats 'research use only' sellers, noting an FDA panel voted to add six peptides despite staff advising against all seven.
Judge Zahid Quraishi found Novo failed to show irreparable harm, so Lilly's superiority ads stay up while the false advertising suit continues.
Researchers found remission was far more likely after bariatric surgery than with intensive medical and lifestyle care over the long run.
A primer on how oral Wegovy is used and where it differs from the weekly injection. Mostly background for people weighing the two forms.
Loading…